|1.||Nishibe, Sansei: 1 article (01/2012)|
|2.||Soya, Hideaki: 1 article (01/2012)|
|3.||Yamaguchi, Akihiko: 1 article (01/2012)|
|4.||Matsui, Takashi: 1 article (01/2012)|
|5.||Ogata, Masato: 1 article (01/2012)|
|6.||Fujikawa, Takahiko: 1 article (01/2012)|
|7.||Hosoo, Shingo: 1 article (01/2012)|
|8.||Nakajima, Kenji: 1 article (01/2012)|
|9.||Yurugi, Yutaka: 1 article (01/2012)|
|10.||Wada, Atsunori: 1 article (01/2012)|
01/01/2012 - "Asperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activity."
03/15/2011 - "These results suggest that asperuloside in Eucommia leaves has important anti-obesity effects."
03/15/2011 - "In this Letter, we examined the anti-obesity effect of Eucommia green leaf extract (EGLE) divided into five fractions with high porous polystyrene gel and of the compounds isolated, geniposidic acid, asperuloside and chlorogenic acid, respectively. "
|2.||Body Weight (Weight, Body)
03/15/2011 - "Chronic administration of isolated asperuloside in Eucommia leaves suppressed increases in model mouse body weight, white adipose tissue weight, plasma triglyceride levels and free fatty acids levels. "
03/15/2011 - "After 4 weeks, body weight, white adipose tissue weight, plasma triglyceride levels and total cholesterol levels in the model mice were significantly inhibited by the 30% MeOH fraction (containing much higher levels of asperuloside than the other fractions), and these effects were similar to those of EGLE. "
|2.||Nonesterified Fatty Acids (NEFA)